EMA - EMA and EORTC multi-stakeholder Follow-up workshop on soft tissue and bone sarcoma 24 May 2024: meeting report and event materials now available

The European Medicines Agency (EMA) and the European Organisation of Research and Treatment of Cancer (EORTC) organised a workshop on soft tissue and bone sarcoma on 12th January 2024 addressing the question on how we can develop new treatments in ultra-rare sarcomas, as a model for ultra-rare tumours. This second workshop, held the 24 May 2024, was organised to discuss more in depth certain aspects as a follow-up discussion. Specifically, the workshop covered topics such as how to support ...